29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MAIT cells and pathogen defense.

      1
      Cellular and molecular life sciences : CMLS

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mucosa-associated invariant T (MAIT) cells are a unique population of innate T cells that are abundant in humans. These cells possess an evolutionarily conserved invariant T cell receptor α chain restricted by the nonpolymorphic class Ib major histocompatibility (MHC) molecule, MHC class I-related protein (MR1). The recent discovery that MAIT cells are activated by MR1-bound riboflavin metabolite derivatives distinguishes MAIT cells from all other αβ T cells in the immune system. Since mammals lack the capacity to synthesize riboflavin, intermediates from the riboflavin biosynthetic pathway are distinct microbial molecular patterns that provide a unique signal to the immune system. Multiple lines of evidence suggest that MAIT cells, which produce important cytokines such as IFN-γ, TNF, and IL-17A, have the potential to influence immune responses to a broad range of pathogens. Here we will discuss our current understanding of MAIT cell biology and their role in pathogen defense.

          Related collections

          Author and article information

          Journal
          Cell. Mol. Life Sci.
          Cellular and molecular life sciences : CMLS
          1420-9071
          1420-682X
          Dec 2014
          : 71
          : 24
          Affiliations
          [1 ] Division of Bacterial Parasitic and Allergenic Products, Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, 1401 Rockville Pike HFM-431, Rockville, MD, 20852, USA, siobhan.cowley@fda.hhs.gov.
          Article
          10.1007/s00018-014-1708-y
          25164578
          53b7615b-9fed-4363-b795-6cace4b01756
          History

          Comments

          Comment on this article